Improved Oral Health in Adults with X-Linked Hypophosphatemia Treated with Burosumab.
Agathe HervéMargaux GadionJulia HerrouMathieu IzartAgnès LinglartMartine Cohen-SolalAnne-Lise LecoqPeter KamenickỷKarine BriotCatherine ChaussainMartin Biosse DuplanPublished in: The Journal of clinical endocrinology and metabolism (2024)
We observed that adults with XLH treated with burosumab developed fewer endodontic infections during dental follow-up than patients who were untreated or received CT.